US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
Fierce Pharma2d
Manufacturing issues trip up Milestone's long-awaited FDA landmark
Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has been a ...
The Manila Times4d
Alvotech Reports Record Results for 2024 and Provides Business Update
Alvotech will conduct a business update conference call and live webcast on Thursday March 27, 2025, at 8:00 am ET (12:00pm ...
Lenz Therapeutics outlines Q4 2025 launch plans for LNZ100 amid FDA review progress
Discover key insights from Lenz Therapeutics' Q4 2024 earnings call, showcasing LNZ100's progress towards launch, a $3B market potential, and FDA ...
Master FDA Inspection Compliance: Join the Virtual FDA Inspection Preparedness Training (May 7-8, 2025)
Join the FDA Inspection Preparedness & Compliance Online Training (May 7-8, 2025) to master regulatory inspection readiness for pharma, biotech, biologics, and medical device industries. This ...
PipelineReview.com14d
Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season
BRIDGEWATER, NJ, USA I March 14, 2025 I Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the manufacturing and ...
Medindia15d
Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season
BRIDGEWATER, N.J., March 14, 2025 /PRNewswire/ -- Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the ...